These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 8969522)
21. Expression of P.69/pertactin from Bordetella pertussis in a baculovirus/insect cell expression system: protective properties of the recombinant protein. Charles I; Rodgers B; Musgrave S; Peakman TC; Chubb A; Fairweather N; Dougan G; Roberts M Res Microbiol; 1993; 144(9):681-90. PubMed ID: 8190994 [TBL] [Abstract][Full Text] [Related]
22. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. King AJ; Berbers G; van Oirschot HF; Hoogerhout P; Knipping K; Mooi FR Microbiology (Reading); 2001 Nov; 147(Pt 11):2885-95. PubMed ID: 11700340 [TBL] [Abstract][Full Text] [Related]
23. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014. Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959 [TBL] [Abstract][Full Text] [Related]
24. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Mooi FR; van Oirschot H; Heuvelman K; van der Heide HG; Gaastra W; Willems RJ Infect Immun; 1998 Feb; 66(2):670-5. PubMed ID: 9453625 [TBL] [Abstract][Full Text] [Related]
25. Antimicrobial Susceptibility and Molecular Detection of Pertactin-producing and Pertactin-Deficient Bordetella pertussis. Souder E; Vodzak J; Evangelista AT; Long SS Pediatr Infect Dis J; 2017 Jan; 36(1):119-121. PubMed ID: 27956730 [TBL] [Abstract][Full Text] [Related]
27. Pertactin is required for Bordetella species to resist neutrophil-mediated clearance. Inatsuka CS; Xu Q; Vujkovic-Cvijin I; Wong S; Stibitz S; Miller JF; Cotter PA Infect Immun; 2010 Jul; 78(7):2901-9. PubMed ID: 20421378 [TBL] [Abstract][Full Text] [Related]
28. Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor. Hovingh ES; Mariman R; Solans L; Hijdra D; Hamstra HJ; Jongerius I; van Gent M; Mooi F; Locht C; Pinelli E Emerg Microbes Infect; 2018 Mar; 7(1):39. PubMed ID: 29559630 [TBL] [Abstract][Full Text] [Related]
29. The evolving nature of Tsang RSW; Shuel M; Cronin K; Deng S; Whyte K; Marchand-Austin A; Ma J; Bolotin S; Crowcroft N; Schwartz K; Van Domselaar G; Graham M; Jamieson FB Can J Microbiol; 2019 Nov; 65(11):823-830. PubMed ID: 31295416 [TBL] [Abstract][Full Text] [Related]
30. Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Mooi FR; He Q; van Oirschot H; Mertsola J Infect Immun; 1999 Jun; 67(6):3133-4. PubMed ID: 10338531 [TBL] [Abstract][Full Text] [Related]
31. Adaptive evolution of the Bordetella autotransporter pertactin. Diavatopoulos DA; Hijnen M; Mooi FR J Evol Biol; 2006 Nov; 19(6):1931-8. PubMed ID: 17040390 [TBL] [Abstract][Full Text] [Related]
32. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. Cassiday P; Sanden G; Heuvelman K; Mooi F; Bisgard KM; Popovic T J Infect Dis; 2000 Nov; 182(5):1402-8. PubMed ID: 11023463 [TBL] [Abstract][Full Text] [Related]